loader
Please Wait
Applying Filters...

Abon Pharmaceuticals's list of EU CTD Dossiers, Marketing Authorizations, In, Out Licensing Opportunities & Finished Dosage Formulations aggregated by PharmaCompass

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1ATOVAQUONE

02 1CLOFARABINE

03 1SUCRALFATE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

Brand Name : ATOVAQUONE

Luxepack
Not Confirmed
arrow

Brand Name : ATOVAQUONE

arrow
Luxepack
Not Confirmed

Abon Pharmaceuticals

Dosage Form : SUSPENSION;ORAL

Brand Name : ATOVAQUONE

Dosage Strength : 750MG/5ML

Packaging :

Approval Date : 2021-10-25

Application Number : 214272

Regulatory Info : RX

Registration Country : USA

blank

02

Brand Name : CLOFARABINE

Luxepack
Not Confirmed
arrow

Brand Name : CLOFARABINE

arrow
Luxepack
Not Confirmed

Abon Pharmaceuticals

Dosage Form : SOLUTION;INTRAVENOUS

Brand Name : CLOFARABINE

Dosage Strength : 20MG/20ML (1MG/ML)

Packaging :

Approval Date : 2017-05-09

Application Number : 204029

Regulatory Info : RX

Registration Country : USA

blank

03

Brand Name : SUCRALFATE

Luxepack
Not Confirmed
arrow

Brand Name : SUCRALFATE

arrow
Luxepack
Not Confirmed

Abon Pharmaceuticals

Dosage Form : SUSPENSION;ORAL

Brand Name : SUCRALFATE

Dosage Strength : 1GM/10ML

Packaging :

Approval Date : 2024-03-21

Application Number : 216726

Regulatory Info : RX

Registration Country : USA

blank